infectious disease

Dr. Robert Redfield: In His Own Words

By Robert Redfield, MD on April 15, 2020
Research!America hosted an alliance member call for members and partners on April 13, 2020 with Dr. Robert Redfield, Director, Centers for Disease Control and Prevention. Dr. Redfield opened with an overview of the COVID-19 pandemic and the CDC’s response. He stressed that COVID-19 is the greatest public health challenge the United States has faced in over a century and highlighted the CDC’s deployment of personnel, development and expansion of serology testing, and distribution of funding to state, local, and tribal public health departments. He also emphasized that our nation should use this time to expand the existing public health infrastructure in order to be better prepared for future...
Continue Reading

Experts Discuss Preparedness for Infectious Disease Outbreaks and Public Perception of Vaccines

By Research!America on May 21, 2018
Flu pandemics and other disease outbreaks underscore the need for vaccines and public health infrastructures to protect individuals against global health threats, said leaders representing government, scientific societies and advocacy groups at a briefing hosted by Research!America and the American Society for Microbiology (ASM) at the Newseum in Washington, D.C. on May 21. The program coincided with the opening of the Smithsonian’s exhibit Outbreak: Epidemics in a Connected World. Seventy-percent of Americans say the federal government should do more to educate the public about global disease outbreaks and the risk to the U.S., according to a new national survey commissioned by Research!...
Continue Reading

A Weekly Advocacy Message from Mary Woolley: Rescission Decision

By Mary Woolley on May 10, 2018
Dear Research Advocate: On Tuesday, President Trump officially sent his rescissions package to Congress, impounding $15.4 billion in discretionary and mandatory spending authority and requesting that Congress rescind (cancel) it. While uncertainty still reigns, it appears that both Houses will, in fact, go through the process of formally reviewing the rescissions package. Members of Congress have a 45-day window to act; if they don’t, it’s back to business as usual. Here is a quick primer the Committee for a Responsible Federal Budget put together on the rescissions process. Among the discretionary and mandatory funding cuts included in the package: $400 million in Ebola funding and $800...
Continue Reading

Impacting Public Health: People, Animals and the Environment

By Rebecca Kaplan, Ph.D. on October 24, 2016
This blog post is part of a weekly series focusing on different aspects of public health leading up to Public Health Thank You Day on Monday, November 21, 2016. Join the conversation on social media with the hashtag #PHTYD and visit www.publichealththankyouday.org for more information. While One Health or One Medicine is a relatively new idea, humans have long recognized the connection between animals, humans, the environment and health. Chinese scholars in the last three centuries BCE interpreted the earth and human body as interdependent and that if the land was unhealthy so was the body. Writings from the Hippocratic Corpus (composed between the sixth and fourth century BCE) include...
Continue Reading

Olympic Games Shine Light on Need for New Antibiotics

By Johan S. Bakken, M.D., Ph.D. on August 8, 2016
For athletes and spectators who are attending the Olympic Games this month, the threat of deadly antibiotic resistant bacteria is all too real. Recently the “bad bug” carbapenemase-producing Klebsiella pneumonia (KPC) was discovered in the waters off several beaches of Rio, where rowing, canoeing and swimming events are scheduled to occur. KPC is one example of antibiotic resistant bacteria, which already sicken at least two million Americans every year. If people visiting Rio for the Olympics become infected with KPC, they may bring it back home, quickly spreading this dangerous bacterium around the world. Without support for new antibiotic R&D, such as the 21 st Century Cures Act,...
Continue Reading

A Weekly Advocacy Message from Mary Woolley: No rest during “recess”!

By researchamerica on May 30, 2013
Dear Research Advocate: Yesterday, President Obama tweeted about the effects of sequestration on medical research. From @barackobama, “The #sequester is slowing the pace of medical research, delaying the discovery of cures and treatments. Read more .” It is terrific that the president is helping drive increased attention to medical research. Our thanks to him and also to all who have joined our Memorial Day recess week of social media advocacy . The American Heart Association posted this great image to its Facebook page; we also thank Society for Neuroscience , BIO , The Endocrine Society , Melanoma Research Alliance , University of Maryland School of Medicine , CURE Epilepsy and UPenn...
Continue Reading

Twitter

Tags

21st Century Cures advocacy Advocacy Awards AHRQ Alzheimer's biomedical research Campaign for Cures cancer CDC COVID-19 FDA global health health research innovation Mary Woolley medical progress medical research mental health National Health Research Forum National Institutes of Health NIH NSF public health Public Health Thank You Day research Research!America science sequestration weekly letter weekly message
More

Blogroll

Previous Posts

September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018

Take Action

 

Contact Congress

 

Get Informed

 

Become a Member

 

Make a Donation

How Can I Help?

Don't leave advocacy to others: sign up for our advocacy alerts and send a message through our website.

Other Advocacy Tools:

Sidebar Quote

If concerted, long-term investments in research are not made, America will lose an entire generation of young scientists.
Brenda Canine, PhD; McLaughlin Research Institute, Montana